Work

The role and regulation of potassium ion channels in endometrium of women with Recurrent Implantation Failure (RIF)

Year: 2019
Type: dissertation
Abstract: Infertility affects 1 in 7 heterosexual couples in the UK. One of the main causes of primary infertility is unexplained infertility (25%), which is linked to recurrent failure of implantation (RIF). Successful embryo implantation is a process which requires both synchronous development and interaction between the hatched blastocyst and endometrium. Endometrial receptivity is key to successful implantation and understanding its molecular determinants may hold important clues for implantation defects. Endometrial cells are exposed to constantly changing microenvironment al factors, typically pH, lipids, oxygen tension, and electrolytes including a six-fold higher potassium (K+) concentration than is found in plasma. These potassium channels are notable for their unique structure and biophysical properties and may play an important role in fertilisation, blastocyst cleavage, modulating endometrial receptivity and embryo implantation. The hypothesis is that potassium channels of human endometrium are differentially expressed during the window of implantation and potassium channel dysregulation may affect their function and that this may contribute to implantation failure. Since many immunotherapies for RIF have been proposed, with variable reported success rates, a meta-analysis was carried out to compare these treatments. The rationale for this was that an improved understanding of endometrial potassium channels may help with the future selection and use of treatments. Ten treatments were selected (glucocorticoids, granulocyte colony stimulating factor (GCSF), heparin, Intralipid, intravenous immune globulin (IVIG), leukocyte inhibitory factor (LIF), lymphocyte immune therapy (LIT), peripheral blood mononuclear cells (PBMC) and TNF-α inhibitors) for their effects on live birth rates and miscarriage rates as primary outcomes in women with recurrent implantation failure (RIF), undergoing IVF or via ICSI. Since Intralipid is composed of phospholipids and fatty acids that are proven to modify potassium channel activity, this treatment was chosen and tested on endometrium to observe its possible effect on potassium channel expression. Potassium channels are expressed in endometrium but their function in this tissue is not understood. A lab-based study was therefore conducted to examine transepithelial electrical resistance (TEER) to define the ability of endometrial monolayers to regulate the control of the potassium flux and hence understand their role in endometrium. This physiological approach was complemented with a molecular study by which changes in the expression of select potassium ion channels (KCNK9, KCNK10, KCNK17, and KCNMA1) were tested through the menstrual cycle and in between mid-secretory fertile and mid secretory infertile human endometrium. In addition, treatment effects of intralipid as well as vitamin D and hypoxia (5% O2) were examined. The same study was conducted on decidual tissue since it is composed mainly of stromal cells and any changes in gene expression from endometrium could be caused by the cell population. Flow cytometry was undertaken to detect potassium channel proteins translation at the single cell level in both endometrium and decidual cells. To understand the epigenetic regulation of the potassium channels expression, DNA methylation profile at the promoter region of the tested channel genes were examined to determine any association between the changes in expression observed in the endometrium with changes in DNA methylation. This was carried out after producing a new protocol for the new EpiQuik™ Tissue Methylated DNA Immunoprecipitation Kit, to work optimally with endometrium and decidual tissue. The preliminary meta-analysis results presented show some evidence that intralipid, PBMC, heparin and to a lesser extent GCSF may have some beneficial effects. These findings have to be interpreted with extreme caution because there are risks attached to these treatments, some of which are very serious. Regarding TEER results, TEER was decreased in 5% O2 (n = 6) in comparison with the control (n=8) (P<0.005). Also, TEER was decreased in both KCNK9 blocker (n = 6) and KCNMA1 blocker (n =6) in comparison with the control (n=8) (P<0.001), while no statistically significant difference was found between the control vs Intralipids and Vitamin D. For the potassium channels expression, KCNK17 showed significant altered expression (P <0.05) in proliferative phase (n = 6) in comparison to secretory phase (n = 10). Also, KCNK17 was significantly downregulated in infertile mid-secretory endometrium (n = 6) in comparison to fertile mid-secretory endometrium (n = 4) (P <0.05). When mid-secretory infertile endometrial samples were tested after treating them with 5% O2 (n = 6), Intralipids (n = 7) and Vitamin D (n = 7), none of the channels showed significant altered expression (P >0.05) in comparison to the control group (n = 12). Translation to protein for the potassium channels was confirmed by flow cytometry. A new protocol for the new EpiQuik™ Tissue Methylated DNA Immunoprecipitation Kit was produced and a pilot study was carried out, showing a hypermethylation of the KCNK17 gene in the fertile mid-secretory endometrium. The findings from this study provided new knowledge on the role of potassium channels in endometrium, especially KCNK17 that is found to contribute to normal and infertile endometrial function. This demonstrates the involvement of potassium channels in the uterine electrolyte transport and intra-uterine fluid amount and composition which is clinically important in endometrial receptivity and embryo adherence and attachment to endometrium.
Language: English
Subfield: Immunology
Open Access status: green
OpenAlex ID: W7217368426
Cites: 281
Cited by:
Related to: 10